Kodama Yoshihisa, Abo Daisuke, Sakuhara Yusuke, Sawada Akihiro, Watanabe Yoshiaki, Funakubo Masakatsu, Shimizu Tadashi, Miyasaka Kazuo
Department of Radiology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
Radiat Med. 2005 Jun;23(4):303-7.
A 35-year-old woman with five renal cell carcinomas (RCCs) was treated by percutaneous cryoablation. She had two RCCs in the left kidney and three in the right. Cryoablation was performed using a high-pressure argon-based system with 2- or 3-mm cryoprobes under magnetic resonance (MR) guidance. Three tumors were completely ablated. Two tumors were residual, as they were so close to nearby organs that we were forced to stop the freezing to avoid complications. No complications were encountered, and renal function was preserved. In conclusion, MR-guided cryoablation is a safe procedure even when RCCs are bilateral and multiple.
一名患有五个肾细胞癌(RCC)的35岁女性接受了经皮冷冻消融治疗。她左肾有两个RCC,右肾有三个。在磁共振(MR)引导下,使用基于高压氩气的系统和2毫米或3毫米的冷冻探针进行冷冻消融。三个肿瘤被完全消融。两个肿瘤有残留,因为它们离附近器官非常近,我们被迫停止冷冻以避免并发症。未出现并发症,肾功能得以保留。总之,即使RCC为双侧且多发,MR引导下的冷冻消融也是一种安全的手术。